Green light for OTC naloxone

Addiction specialists have welcomed a move to reschedule the opioid antidote naloxone as an over-the-counter product, but have questioned whether patients will receive appropriate counselling on its use from pharmacists.

The TGA's Advisory Committee on Medicines Scheduling (ACMS) last week recommended that single-use prefilled syringe preparations of naloxone be changed from prescription only to OTC from 1 February 2016.

In reaching its decision, the committee said there had been unanimous support for the move in submissions to the TGA, which pointed to the